1,3,6‐Tri‐O‐Galloyl‐β‐D‐Glucose Alleviates Sepsis‐Induced Lung Damage by Inhibiting Inflammatory Response and Oxidative Stress Through Targeting Neutrophil <scp>IFIT1</scp>

Respiratory failure is a common complication of sepsis, affecting approximately 20% of patients in intensive care units worldwide, with a high mortality rate of 30%-40%. Excessive immune responses exacerbate lung damage in sepsis,; however, the key mechanisms determining survival versus susceptibility remain elusive. Elucidation of the key pathways underlying lung injury may provide novel therapeutic strategies for septic respiratory failure. This study aimed to elucidate key mechanisms regulating excessive immune responses and determining sepsis outcomes, and to provide novel intervention strategies for sepsis treatment. To achieve the above objectives, we analyzed septic immune cell heterogeneity and survival-associated hallmark genes using published single-cell RNA sequencing data from septic mice. We identified a subset of Ifit1<sup>high</sup> neutrophils with tissue-protective potential and validated this finding using flow cytometry. Building on this, to further delineate the specific mechanism by which Ifit1 governs neutrophil immune function and thereby mediates tissue protection, our RNA sequencing-based analysis revealed that IFIT1 modulates both NFκB-driven inflammation and the NADPH oxidase pathway, ultimately conferring an anti-inflammatory effect. Furthermore, we conducted virtual screening and molecular docking to shortlist compounds with potential IFIT1-activating properties from a library of 4500 compounds. The natural compound 1,3,6-Tri-O-galloyl-β-D-glucose (TGG) demonstrated potent IFIT1 agonism, reducing LPS-induced acute inflammation both in vitro and in vivo. In summary, our research confirms that IFIT1 in neutrophils represents a novel therapeutic target for mitigating septic inflammatory storms and pulmonary dysfunction. The natural product TGG, as a potent activator of IFIT1, is a promising candidate for treating septic lung injury.

Authors

Institutions

Publication Details

Journal
The FASEB Journal
Published
2026-01-02
DOI
https://doi.org/10.1096/fj.202503249r
Primary Topic
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

1,3,6‐Tri‐O‐Galloyl‐β‐D‐Glucose Alleviates Sepsis‐Induced Lung Damage by Inhibiting Inflammatory Response and Oxidative Stress Through Targeting Neutrophil IFIT1

X Li, Liyun Cao, Guodong Zhao, Shenrao Zheng et al.
The FASEB Journal
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
article

1,3,6‐Tri‐O‐Galloyl‐β‐D‐Glucose Alleviates Sepsis‐Induced Lung Damage by Inhibiting Inflammatory Response and Oxidative Stress Through Targeting Neutrophil IFIT1

X Li, Liyun Cao, Guodong Zhao, Shenrao Zheng, Jiayi Gao, Xiaohui Zhang
article en

Abstract

Respiratory failure is a common complication of sepsis, affecting approximately 20% of patients in intensive care units worldwide, with a high mortality rate of 30%-40%. Excessive immune responses exacerbate lung damage in sepsis,; however, the key mechanisms determining survival versus susceptibility remain elusive. Elucidation of the key pathways underlying lung injury may provide novel therapeutic strategies for septic respiratory failure. This study aimed to elucidate key mechanisms regulating excessive immune responses and determining sepsis outcomes, and to provide novel intervention strategies for sepsis treatment. To achieve the above objectives, we analyzed septic immune cell heterogeneity and survival-associated hallmark genes using published single-cell RNA sequencing data from septic mice. We identified a subset of Ifit1<sup>high</sup> neutrophils with tissue-protective potential and validated this finding using flow cytometry. Building on this, to further delineate the specific mechanism by which Ifit1 governs neutrophil immune function and thereby mediates tissue protection, our RNA sequencing-based analysis revealed that IFIT1 modulates both NFκB-driven inflammation and the NADPH oxidase pathway, ultimately conferring an anti-inflammatory effect. Furthermore, we conducted virtual screening and molecular docking to shortlist compounds with potential IFIT1-activating properties from a library of 4500 compounds. The natural compound 1,3,6-Tri-O-galloyl-β-D-glucose (TGG) demonstrated potent IFIT1 agonism, reducing LPS-induced acute inflammation both in vitro and in vivo. In summary, our research confirms that IFIT1 in neutrophils represents a novel therapeutic target for mitigating septic inflammatory storms and pulmonary dysfunction. The natural product TGG, as a potent activator of IFIT1, is a promising candidate for treating septic lung injury.

The FASEB JournalVol. 40(1)
China Pharmaceutical University (CN)
Good health and well-being
Openalex Percentile: Top 99%
Neutrophil, Myeloperoxidase and Oxidative Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

1,3,6‐Tri‐O‐Galloyl‐β‐D‐Glucose Alleviates Sepsis‐Induced Lung Damage by Inhibiting Inflammatory Response and Oxidative Stress Through Targeting Neutrophil <scp>IFIT1</scp> — X Li, Liyun Cao, et al. · The FASEB Journal (2026) | TGRS Research Map | TGRS